FIELD: biotechnology; pharmaceutics.
SUBSTANCE: invention relates to biotechnology and pharmaceutics. Disclosed is use of a peptide of formula β-aspartyl-proline: H-Asp(Pro)-OH for improving functional activity of bronchial mucosa cells.
EFFECT: peptide has biological activity expressed in activation of proliferation and reduction of apoptosis, as well as activation of protective functions of bronchial mucosa cells, and can be used for treating chronic bronchitis.
4 cl, 2 tbl, 3 ex
Authors
Dates
2022-03-17—Published
2021-05-27—Filed